Suneva Medical, Inc., a privately held aesthetics company, announces the appointment of Vince Ippolito to its Board of Directors.
Ippolito has over 30 years of experience in the pharmaceuticals industry, including 20 years in dermatology and aesthetic medicine. He most recently served as the chief commercial officer and executive vice president of Anacor Pharmaceuticals until Sept 2017, where he was responsible for developing marketing and sales functions, as well as strategizing the company's product portfolio.
Prior, Ippolito was executive vice president and chief commercial officer at Medicis, a leading dermatology and aesthetic medicine company, who brought Restylane and Dysport to Market in the US.
Throughout his career, Ippolito has launched more than 20 brands in dermatology and aesthetic medicine. He took a leading role in two of the largest dermatology acquisitions in the past five years totaling $7.8 billion.
Preston Romm, president/CEO, Suneva, said, “We are very excited to have Vince join our board. His experience and knowledge of the dermatology market and specifically, the aesthetics market, is invaluable. Together with Dennis Condon, he will help take Suneva to the next level."